We are live on ! Find out more
First Manhattan

First Manhattan Portfolio holdings

AUM $36.1B
1-Year Est. Return 11.5%
This Fund
S&P 500
This Quarter Est. Return
-0.07%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.1B
AUM Growth
-$250M
Cap. Flow
+$8.92M
Cap. Flow %
0.03%
Top 10 Hldgs %
55.27%
Holding
1,748
New
132
Increased
271
Reduced
387
Closed
93

Top Buys

Rank Stock Value
1
PPLI
People Inc
PPLI
+$92.9M
2
AMZN icon
Amazon
AMZN
+$62.6M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
+$46.3M
4
VMEO
Vimeo
VMEO
+$33.1M
5
UNH icon
UnitedHealth
UNH
+$28M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$49.9M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$43.5M
3
HUM icon
Humana
HUM
+$36.6M
4
VIPS icon
Vipshop
VIPS
+$35.6M
5
BN icon
Brookfield
BN
+$24M

Sector Composition

Rank Sector Weight
1 Financials 41.6%
2 Technology 16.13%
3 Healthcare 10.46%
4 Consumer Discretionary 9.11%
5 Communication Services 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBT
1401
Beacon Financial Corp
BBT
$2.53B
$4K ﹤0.01%
180
-90
-33% -$2.38K
BLDP
1402
Ballard Power Systems
BLDP
$874M
$4K ﹤0.01%
300
BMRN icon
1403
BioMarin Pharmaceuticals
BMRN
$11.5B
$4K ﹤0.01%
60
BUR icon
1404
Burford Capital
BUR
$907M
$4K ﹤0.01%
450
BWG
1405
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$131M
$4K ﹤0.01%
350
CASY icon
1406
Casey's General Stores
CASY
$31.9B
$4K ﹤0.01%
24
DG icon
1407
Dollar General
DG
$25.9B
$4K ﹤0.01%
19
DY icon
1408
Dycom Industries
DY
$12.9B
$4K ﹤0.01%
+65
New +$4.59K
ESPR
1409
DELISTED
Esperion Therapeutics
ESPR
$4K ﹤0.01%
410
EXP icon
1410
Eagle Materials
EXP
$6.6B
$4K ﹤0.01%
+33
New +$4.74K
FLS icon
1411
Flowserve
FLS
$9.25B
$4K ﹤0.01%
+125
New +$4.89K
GDRX icon
1412
GoodRx Holdings
GDRX
$1B
$4K ﹤0.01%
100
GENC icon
1413
Gencor Industries
GENC
$223M
$4K ﹤0.01%
+425
New +$4.91K
GERN icon
1414
Geron
GERN
$911M
$4K ﹤0.01%
3,200
HAL icon
1415
Halliburton
HAL
$27.9B
$4K ﹤0.01%
200
HWM icon
1416
Howmet Aerospace
HWM
$116B
$4K ﹤0.01%
133
IEI icon
1417
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
$4K ﹤0.01%
36
KALA icon
1418
KALA BIO
KALA
$11.8M
$4K ﹤0.01%
1
LNN icon
1419
Lindsay Corp
LNN
$1.16B
$4K ﹤0.01%
+30
New +$4.84K
MSB
1420
Mesabi Trust
MSB
$295M
$4K ﹤0.01%
+150
New +$5.01K
MTZ icon
1421
MasTec
MTZ
$26.7B
$4K ﹤0.01%
+55
New +$5.22K
MYRG icon
1422
MYR Group
MYRG
$5.9B
$4K ﹤0.01%
+50
New +$4.92K
NVEE
1423
DELISTED
NV5 Global
NVEE
$4K ﹤0.01%
+200
New +$4.93K
OR icon
1424
OR Royalties Inc
OR
$5.47B
$4K ﹤0.01%
400
PB icon
1425
Prosperity Bancshares
PB
$8.77B
$4K ﹤0.01%
69

Similar funds

First Manhattan's Q3 2021 Portfolio in Review

As of Q3 2021, First Manhattan held 1,748 positions worth $27.1B, down 0.91% from $27.4B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

First Manhattan's Q3 2021 filing shows 132 new, 271 increased, 387 reduced and 93 closed positions. Its largest new stake was Immunocore: 197,999 shares worth $7.34M. The largest sale was Amgen, an estimated $49.9M.

By sector, the portfolio is most concentrated in Financials at 42% of assets, down from 42% a quarter earlier, followed by Technology and Healthcare.

  • First Manhattan's largest Q3 2021 buy was Immunocore: 197,999 shares worth $7.34M.
  • First Manhattan added most to People Inc in Q3 2021, an estimated $92.9M increase.
  • First Manhattan's biggest Q3 2021 reduction was Amgen, cutting an estimated $49.9M.
  • First Manhattan fully exited Humana in Q3 2021, selling an estimated $36.6M.
  • First Manhattan's ten largest holdings make up 55% of its $27.1B portfolio in Q3 2021.
  • First Manhattan opened 132 new positions and closed 93 in Q3 2021.
  • First Manhattan's portfolio value fell 0.91% quarter-over-quarter to $27.1B.

Based on First Manhattan's 13F filing for Q3 2021, filed 15 Nov 2021.